This inventor holds 2 USPTO granted patents. Top assignee: Novartis Ag. Active years: 2011-2012.
Company Filing History:
Years Active: 2011-2012
Title: The Innovations of Jean-Michel Grenet
Introduction
Jean-Michel Grenet is a notable inventor based in Village Neuf, France. He has made significant contributions to the field of pharmaceuticals, particularly in drug monitoring assays. With a total of two patents to his name, Grenet's work focuses on enhancing the specificity of binding agents for pharmaceutically active compounds.
Latest Patents
Grenet's latest patents revolve around a method for obtaining binding agents that exhibit higher specificity for pharmaceutically active forms of compounds compared to their inactive counterparts. This innovative approach utilizes special derivatives of the parent compound. The patents also cover the creation of these binding agents and derivatives, as well as the drug monitoring assays that employ them for tracking the active forms of the parent compound.
Career Highlights
Jean-Michel Grenet is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to further develop his innovative ideas and contribute to advancements in drug monitoring technologies.
Collaborations
Grenet collaborates with esteemed colleagues such as Patrick Albientz and Rainer Hillenbrand. Their combined expertise enhances the research and development efforts within their projects.
Conclusion
Jean-Michel Grenet's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to impact drug monitoring technologies positively.